Q2 2026 Recursion Pharmaceuticals, Inc. Earnings Call Transcript
Good morning everyone, and thank you for joining us.
Before we begin, I'd like to remind everyone that today's discussion will include forward-looking statements.
Next slide. Please refer to today's press release and our SEC filings for additional details.
At Recursion, our mission is to decode biology to radically improve patient lives.
And we do this by building transformational medicines with an AI native product engine.
Over the past year, we have reached an important inflection point.
We are no longer just discussing the potential of our platform. We are demonstrating the ability of our AI native product engine to generate differentiated programs and medicines.
Just as a reminder, the engine you see on the left-hand side is built as a continuous learning system.
Proprietary multimodal data created in our data factory powers frontier AI models. And these models then generate new hypotheses where every single prediction is tested
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
